TrialCirculation2018

Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease.

Johannes F E Mann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.